Profound MedicalPROF -4.74%69 1-Year Share Buyback Ratio is -20.90 as of Mar. 2026. GuruFocus rates PROF with a GF Score™ of 69/100 and a GF Value™ of $14.65 (Possible Value Trap). The stock has 1 warning sign investors should review. Among 536 Medical Devices & Instruments companies, Profound Medical ranks worse than 76.87% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Profound Medical's current 1-Year Share Buyback Ratio was -20.90%.
PROF's 1-Year Share Buyback Ratio is ranked worse than 76.87% of 536
companies
in the Medical Devices & Instruments industry
Industry Median: -2.9
vs PROF: -20.90
Profound Medical (NAS:PROF) 1-Year Share Buyback Ratio Explanation
A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Profound Medical 1-Year Share Buyback Ratio Related Terms
PROF vs ABT, SYK, MDT: 1-Year Share Buyback Ratio Comparison
For the Medical Devices subindustry, Profound Medical's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Profound Medical 1-Year Share Buyback Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Profound Medical's 1-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Profound Medical's 1-Year Share Buyback Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a 1-Year Share Buyback Ratio of -20.90 mean?
Profound Medical (PROF) has a 1-Year Share Buyback Ratio of -20.90 as of Mar. 2026. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for Profound Medical and its competitors. According to the industry distribution chart, Profound Medical ranks #412 out of 536 companies in the Medical Devices & Instruments industry, placing it in the top 76.9%.
Is Profound Medical's 1-Year Share Buyback Ratio too high?
Profound Medical's current 1-Year Share Buyback Ratio is -20.90. Based on the distribution chart, Profound Medical ranks #412 out of 536 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Profound Medical has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Profound Medical's 1-Year Share Buyback Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Profound Medical ranks #412 out of 536 companies for 1-Year Share Buyback Ratio. This places Profound Medical in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Share Buyback Ratio for a Medical Devices & Instruments company?
A good 1-Year Share Buyback Ratio depends on the Medical Devices & Instruments industry context. However, 1-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Share Buyback Ratio mean?
A high 1-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for Profound Medical and its competitors. Profound Medical's current 1-Year Share Buyback Ratio is -20.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Profound Medical stock overvalued right now?
Based on GuruFocus' analysis, Profound Medical (PROF) is currently considered Possible Value Trap. The stock's GF Value™ is $14.65, compared to a current price of $7.04 — trading 51.9% below its estimated fair value. The current 1-Year Share Buyback Ratio is -20.90. Profound Medical's overall GF Score™ is 69/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Share Buyback Ratio calculated?
1-Year Share Buyback Ratio is calculated from a company's financial statements. For Profound Medical (PROF), the current 1-Year Share Buyback Ratio is -20.90 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Profound Medical (PROF) Overvalued in 2026?
Based on GuruFocus' analysis, Profound Medical stock appears to be undervalued.
The current stock price of $7.04 is trading 51.9% below its estimated GF Value™ of $14.65.
GuruFocus considers Profound Medical to be Possible Value Trap.
Key valuation signals for PROF:
1-Year Share Buyback Ratio: -20.90
GF Value™: $14.65 vs. price of $7.04 (51.9% below fair value)
No single metric tells the full story. See the PROF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
69GF Score
Get the complete analysis for PROF
1-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PROF has been successfully added to your 